GL1X · GenesisL1 explorer

MolNFT v1 · #15868 · protein

Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor

1NHV · Hepatitis C virus NS5B RNA-dependent RNA polymerase: “Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor”. X-ray diffraction, 1 ligand (154), 13 pockets (best druggability 0.80). MolNFT v1 #15868 on…

PDB
1NHV
Type
protein
Length
1,119 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
154
Pockets
13 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 47% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatitis C virus NS5B RNA-dependent RNA polymerase (EC 2.7.7.48)protein55847% helix, 14% strandP26663
BHepatitis C virus NS5B RNA-dependent RNA polymerase (EC 2.7.7.48)protein56146% helix, 15% strandP26663

Ligands and binding sites

  • 154 · (2S)-2-[(5-benzofuran-2-yl-thiophen-2-ylmethyl)-(2,4-dichloro-benzoyl)-amino]-3-phenyl-propionic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110810.800.8180empty
210700.800.8182empty
310960.740.7769empty
41200.540.8219empty
5910.490.8215empty

Interfaces

1 interface between chains.

  • A–B · 446 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 1NHV · Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.